NFE2L2 and Parkinson disease: Furthermore, MPP+-induced MDA and ROS in PC12 cells were exacerbated by the Nrf2-inhibitor ML385, which was reversed by morroniside treatment, demonstrating the importance of Nrf2 in morroniside-mediated PD mitigation.